| Characteristic | Revenue in thousand DKK |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Release date
June 2019
Region
Denmark
Survey time period
2008 to 2018
Supplementary notes
Symphogen is a Danish biotechnology company with focus on clinical-stage oncology antibodies.
Some figures have been taken from previous publications.
Citation formats









